WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 8 fonti

GLP-1 Maker Sued Over Ads; Vaginal Estrogen; Melinda Gates Talks Perimenopause

News and commentary from the endocrinology world

Raccontata daforbes.commedpagetoday.comzerohedge.comfiercepharma.comdw.comcbsnews.comendpoints.newsaxios.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
medpagetoday.comStai leggendo1 g fa

GLP-1 Maker Sued Over Ads; Vaginal Estrogen; Melinda Gates Talks Perimenopause

News and commentary from the endocrinology world

originale
zerohedge.com1 g fa

GLP-1 Fight: Novo Sues Eli Lilly Over Nationwide "Deceptive Advertising" Campaign

"Through this action, Novo Nordisk is seeking a permanent injunction requiring Lilly to pull its misleading comparative advertising across all platforms... "

Leggi questa versione → originale
cbsnews.com1 g fa

Novo Nordisk sues Eli Lilly over "maliciously and deceptively false" GLP-1 ads

The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.

Leggi questa versione → originale
fiercepharma.com1 g fa

Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads

Novo Nordisk has accused rival Eli Lilly of runnin | Novo Nordisk has accused Eli Lilly of running ad campaigns containing “deliberately false” messages that mislead the public about the comparative efficacy of GLP-1…

Leggi questa versione → originale
axios.com19 h fa

Novo accuses rival Eli Lilly of "deceptive" weight-loss drug ads

The weight-loss drug wars reached a new level of intensity Tuesday as Novo Nordisk sued Eli Lilly, accusing its arch-rival of misleading advertising.

Leggi questa versione → originale
dw.com1 g fa

Ozempic maker sues US rival over ad campaign

Novo Nordisk has claimed that Eli Lilly is using bad data to compare the companies' weight-loss and diabetes products in its ads.

Leggi questa versione → originale

Timeline cronologica

  1. martedì 21 luglio 2026·forbes.com

    Ozempic Maker Novo Nordisk Sues Eli Lilly For Deceptive Advertising

    The lawsuit, filed in federal court Tuesday, accuses Eli Lilly of using outdated data in advertising campaigns.

  2. martedì 21 luglio 2026·medpagetoday.com

    GLP-1 Maker Sued Over Ads; Vaginal Estrogen; Melinda Gates Talks Perimenopause

    News and commentary from the endocrinology world

  3. martedì 21 luglio 2026·zerohedge.com

    GLP-1 Fight: Novo Sues Eli Lilly Over Nationwide "Deceptive Advertising" Campaign

    "Through this action, Novo Nordisk is seeking a permanent injunction requiring Lilly to pull its misleading comparative advertising across all platforms... "

  4. martedì 21 luglio 2026·fiercepharma.com

    Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads

    Novo Nordisk has accused rival Eli Lilly of runnin | Novo Nordisk has accused Eli Lilly of running ad campaigns containing “deliberately false” messages that mislead the public…

  5. martedì 21 luglio 2026·dw.com

    Ozempic maker sues US rival over ad campaign

    Novo Nordisk has claimed that Eli Lilly is using bad data to compare the companies' weight-loss and diabetes products in its ads.

  6. martedì 21 luglio 2026·cbsnews.com

    Novo Nordisk sues Eli Lilly over "maliciously and deceptively false" GLP-1 ads

    The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.

  7. martedì 21 luglio 2026·endpoints.news

    Novo sues Lilly over 'deceptive' ads comparing GLP-1 drug doses

    Novo Nordisk sues Eli Lilly, alleging its Zepbound ads misleadingly compare doses against outdated Wegovy data.

  8. martedì 21 luglio 2026·axios.com

    Novo accuses rival Eli Lilly of "deceptive" weight-loss drug ads

    The weight-loss drug wars reached a new level of intensity Tuesday as Novo Nordisk sued Eli Lilly, accusing its arch-rival of misleading advertising.